- Home
- JSPR vs ZENV Comparison
JSPR vs ZENV Comparison
Compare JSPR & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JSPR | ZENV |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 16.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | JSPR | ZENV |
|---|---|---|
| Price | $1.41 | $0.40 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $18.13 | N/A |
| AVG Volume (30 Days) | 388.6K | ★ 531.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $0.25 |
| 52 Week High | $7.19 | $2.16 |
Technical Indicators
Market Signals| Indicator | JSPR | ZENV |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 29.31 |
| Support Level | $1.40 | $0.25 |
| Resistance Level | $1.44 | $1.00 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 85.32 | 20.00 |
Price Performance
Historical ComparisonAbout JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.